Literature DB >> 25637041

Role of non-invasive imaging in the work-up of cardiomyopathies.

Lakshmi S Tummala1, Raymond K Young, Tania Singh, Sandeep Jani, Monvadi B Srichai.   

Abstract

Cardiomyopathy is an intrinsic structural disorder of the myocardium that may result in ventricular dysfunction and can progress to clinical heart failure. Non-invasive imaging modalities can determine whether abnormalities are present in the myocardium, valves, pericardium, or vessels. These imaging techniques can also present important prognostic information, as well as direct treatment and further management. Echocardiography is the most common imaging technique used for the initial diagnosis and management of cardiomyopathy; however, other imaging modalities, including nuclear cardiac imaging, cardiac magnetic resonance imaging, and cardiac computed tomography, may play an important role depending on the underlying etiology of the cardiomyopathy. This article reviews the role of non-invasive imaging in the work-up and management of patients with cardiomyopathy.

Entities:  

Mesh:

Year:  2015        PMID: 25637041     DOI: 10.1007/s11883-014-0486-1

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  83 in total

1.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

2.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

3.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

4.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.

Authors:  Harikrishna Tandri; Manoj Saranathan; E Rene Rodriguez; Claudia Martinez; Chandra Bomma; Khurram Nasir; Boas Rosen; João A C Lima; Hugh Calkins; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

5.  Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.

Authors:  Raymond H Chan; Barry J Maron; Iacopo Olivotto; Michael J Pencina; Gabriele Egidy Assenza; Tammy Haas; John R Lesser; Christiane Gruner; Andrew M Crean; Harry Rakowski; James E Udelson; Ethan Rowin; Massimo Lombardi; Franco Cecchi; Benedetta Tomberli; Paolo Spirito; Francesco Formisano; Elena Biagini; Claudio Rapezzi; Carlo Nicola De Cecco; Camillo Autore; E Francis Cook; Susie N Hong; C Michael Gibson; Warren J Manning; Evan Appelbaum; Martin S Maron
Journal:  Circulation       Date:  2014-08-05       Impact factor: 29.690

6.  The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Francisco Alpendurada; Kaushik Guha; Nizar A Ismail; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Kishen Morarji; Emmanouil Liodakis; Michael Roughton; Ricardo Wage; Tapesh C Pakrashi; Rakesh Sharma; John-Paul Carpenter; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

Review 7.  Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis.

Authors:  Kiran R Nandalur; Ben A Dwamena; Asim F Choudhri; Mohan R Nandalur; Ruth C Carlos
Journal:  J Am Coll Cardiol       Date:  2007-09-17       Impact factor: 24.094

8.  Sixty-four-slice multidetector computed tomography: an accurate imaging modality for the evaluation of coronary arteries in dilated cardiomyopathy of unknown etiology.

Authors:  Daniele Andreini; Gianluca Pontone; Antonio L Bartorelli; Piergiuseppe Agostoni; Saima Mushtaq; Erika Bertella; Daniela Trabattoni; Gaia Cattadori; Sarah Cortinovis; Andrea Annoni; Alice Castelli; Giovanni Ballerini; Mauro Pepi
Journal:  Circ Cardiovasc Imaging       Date:  2009-03-24       Impact factor: 7.792

9.  Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects.

Authors:  Benedetta Giorgi; Nico R A Mollet; Steven Dymarkowski; Frank E Rademakers; Jan Bogaert
Journal:  Radiology       Date:  2003-06-11       Impact factor: 11.105

10.  Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).

Authors:  Ian Paterson; George A Wells; Justin A Ezekowitz; James A White; Matthias G Friedrich; Lisa M Mielniczuk; Eileen O'Meara; Benjamin Chow; Rob A DeKemp; Ran Klein; Carole Dennie; Alexander Dick; Doug Coyle; Girish Dwivedi; Miroslaw Rajda; Graham A Wright; Mika Laine; Helena Hanninen; Eric Larose; Kim A Connelly; Howard Leong-Poi; Andrew G Howarth; Ross A Davies; Lloyd Duchesne; Seppo Yla-Herttuala; Antti Saraste; Paul Farand; Linda Garrard; Jean-Claude Tardif; Malcolm Arnold; Juhani Knuuti; Rob Beanlands; Kwan L Chan
Journal:  Trials       Date:  2013-10-12       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.